Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Materials
Create a narrative
Ginkgo Bioworks Holdings Community
NYSE:DNA Community
1
Narratives
written by author
0
Comments
on narratives written by author
47
Fair Values set
on narratives written by author
Create a narrative
Ginkgo Bioworks Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
Ginkgo Bioworks Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Biopharma Demand Will Boost Automation And Data Services
Key Takeaways Shifting towards tools like Ginkgo Automation platform addresses biopharma AI data demand, enhancing revenue through diversification. Expanding customer base and government partnerships in Cell Engineering and Biosecurity aim for sustained revenue growth.
View narrative
US$8.30
FV
5.5% undervalued
intrinsic discount
-0.039%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
44
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
DNA
DNA
Ginkgo Bioworks Holdings
Your Fair Value
US$
Current Price
US$7.84
149.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
478m
2015
2018
2021
2024
2025
2027
2030
Revenue US$211.0m
Earnings US$18.6m
Advanced
Set Fair Value